|
1
|
Wynn TA: Cellular and molecular mechanisms
of fibrosis. J Pathol. 214:199–210. 2008. View Article : Google Scholar
|
|
2
|
Mack M: Inflammation and fibrosis. Matrix
Biol. 68-69:106–121. 2018. View Article : Google Scholar
|
|
3
|
Tang PM, Nikolic-Paterson DJ and Lan HY:
Macrophages: Versatile players in renal inflammation and fibrosis.
Nat Rev Nephrol. 15:144–158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kleaveland KR, Moore BB and Kim KK:
Paracrine functions of fibrocytes to promote lung fibrosis. Expert
Rev Respir Med. 8:163–172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gregory RI, Chendrimada TP, Cooch N and
Shiekhattar R: Human RISC couples microRNA biogenesis and
posttranscriptional gene silencing. Cell. 123:631–640. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM
and Zhang GZ: Biological functions of microRNAs: A review. J
Physiol Biochem. 67:129–139. 2011. View Article : Google Scholar
|
|
7
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu LF, Boldin MP, Chaudhry A, Lin LL,
Taganov KD, Hanada T, Yoshimura A, Baltimore D and Rudensky AY:
Function of miR-146a in controlling Treg cell-mediated regulation
of Th1 responses. Cell. 142:914–929. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang S, Zhang X, Ju Y, Zhao B, Yan X, Hu
J, Shi L, Yang L, Ma Z, Chen L, et al: MicroRNA-146a feedback
suppresses T cell immune function by targeting Stat1 in patients
with chronic hepatitis B. J Immunol. 191:293–301. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boldin MP, Taganov KD, Rao DS, Yang L,
Zhao JL, Kalwani M, Garcia-Flores Y, Luong M, Devrekanli A, Xu J,
et al: miR-146a is a significant brake on autoimmunity,
myeloproliferation, and cancer in mice. J Exp Med. 208:1189–1201.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao JL, Rao DS, Boldin MP, Taganov KD,
O'Connell RM and Baltimore D: NF-kappaB dysregulation in
microRNA-146a-deficient mice drives the development of myeloid
malignancies. Proc Natl Acad Sci USA. 108:9184–9189. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ho BC, Yu IS, Lu LF, Rudensky A, Chen HY,
Tsai CW, Chang YL, Wu CT, Chang LY, Shih SR, et al: Inhibition of
miR-146a prevents enterovirus-induced death by restoring the
production of type I interferon. Nat Commun. 5:33442014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alexander M, Hu R, Runtsch MC, Kagele DA,
Mosbruger TL, Tolmachova T, Seabra MC, Round JL, Ward DM and
O'Connell RM: Exosome-delivered microRNAs modulate the inflammatory
response to endotoxin. Nat Commun. 6:73212015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Paterson MR and Kriegel AJ: MiR-146a/b: A
family with shared seeds and different roots. Physiol Genomics.
49:243–252. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Curtale G, Mirolo M, Renzi TA, Rossato M,
Bazzoni F and Locati M: Negative regulation of Toll-like receptor 4
signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci USA.
110:11499–11504. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kutty RK, Nagineni CN, Samuel W,
Vijayasarathy C, Jaworski C, Duncan T, Cameron JE, Flemington EK,
Hooks JJ and Redmond TM: Differential regulation of microRNA-146a
and microRNA-146b-5p in human retinal pigment epithelial cells by
interleukin-1β, tumor necrosis factor-α, and interferon-γ. Mol Vis.
19:737–750. 2013.
|
|
17
|
Liu R, Liu C, Chen D, Yang WH, Liu X, Liu
CG, Dugas CM, Tang F, Zheng P, Liu Y and Wang L: FOXP3 controls an
miR-146/NF-κB negative feedback loop that inhibits apoptosis in
breast cancer cells. Cancer Res. 75:1703–1713. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Taganov KD, Boldin MP, Chang KJ and
Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an
inhibitor targeted to signaling proteins of innate immune
responses. Proc Natl Acad Sci USA. 103:12481–12486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ni S, Yang B, Xia L and Zhang H: EZH2
mediates miR-146a-5p/HIF-1 α to alleviate inflammation and
glycolysis after acute spinal cord injury. Mediators Inflamm.
2021:55915822021. View Article : Google Scholar
|
|
20
|
Damodaran M, Paul SFD and Venkatesan V:
Genetic polymorphisms in miR-146a, miR-196a2 and miR-125a genes and
its association in prostate cancer. Pathol Oncol Res. 26:193–200.
2020. View Article : Google Scholar
|
|
21
|
Chae YS, Kim JG, Lee SJ, Kang BW, Lee YJ,
Park JY, Jeon HS, Park JS and Choi GS: A miR-146a polymorphism
(rs2910164) predicts risk of and survival from colorectal cancer.
Anticancer Res. 33:3233–3239. 2013.PubMed/NCBI
|
|
22
|
Luo X, Yang W, Ye DQ, Cui H, Zhang Y,
Hirankarn N, Qian X, Tang Y, Lau YL, de Vries N, et al: A
functional variant in microRNA-146a promoter modulates its
expression and confers disease risk for systemic lupus
erythematosus. PLoS Genet. 7:e10021282011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cui L, Tao H, Wang Y, Liu Z, Xu Z, Zhou H,
Cai Y, Yao L, Chen B, Liang W, et al: A functional polymorphism of
the microRNA-146a gene is associated with susceptibility to
drug-resistant epilepsy and seizures frequency. Seizure. 27:60–65.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang JY and Lee JO: Structural biology of
the Toll-like receptor family. Annu Rev Biochem. 80:917–941. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rowe DC, McGettrick AF, Latz E, Monks BG,
Gay NJ, Yamamoto M, Akira S, O'Neill LA, Fitzgerald KA and
Golenbock DT: The myristoylation of TRIF-related adaptor molecule
is essential for Toll-like receptor 4 signal transduction. Proc
Natl Acad Sci USA. 103:6299–6304. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tanimura N, Saitoh S, Matsumoto F,
Akashi-Takamura S and Miyake K: Roles for LPS-dependent interaction
and relocation of TLR4 and TRAM in TRIF-signaling. Biochem Biophys
Res Commun. 368:94–99. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
De Nardo D: Toll-like receptors:
Activation, signalling and transcriptional modulation. Cytokine.
74:181–189. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen LF and Greene WC: Shaping the nuclear
action of NF-kappaB. Nat Rev Mol Cell Biol. 5:392–401. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hoffmann A, Natoli G and Ghosh G:
Transcriptional regulation via the NF-kappaB signaling module.
Oncogene. 25:6706–6716. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo JL, Kamata H and Karin M:
IKK/NF-kappaB signaling: Balancing life and death-a new approach to
cancer therapy. J Clin Invest. 115:2625–2632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hou J, Wang P, Lin L, Liu X, Ma F, An H,
Wang Z and Cao X: MicroRNA-146a feedback inhibits RIG-I-dependent
type I IFN production in macrophages by targeting TRAF6, IRAK1, and
IRAK2. J Immunol. 183:2150–2158. 2006. View Article : Google Scholar
|
|
34
|
He L, Wang Z, Zhou R, Xiong W, Yang Y,
Song N and Qian J: Dexmedetomidine exerts cardioprotective effect
through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the
NF-κB pathway. Biomed Pharmacother. 133:1109932021. View Article : Google Scholar
|
|
35
|
Zhang Z, Zou X, Zhang R, Xie Y, Feng Z, Li
F, Han J, Sun H, Ouyang Q, Hua S, et al: Human umbilical cord
mesenchymal stem cell-derived exosomal miR-146a-5p reduces
microglial-mediated neuroinflammation via suppression of the
IRAK1/TRAF6 signaling pathway after ischemic stroke. Aging (Albany
NY). 13:3060–3079. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hou J, Deng Q, Deng X, Zhong W, Liu S and
Zhong Z: MicroRNA-146a-5p alleviates lipopolysaccharide-induced
NLRP3 inflammasome injury and pro-inflammatory cytokine production
via the regulation of TRAF6 and IRAK1 in human umbilical vein
endothelial cells (HUVECs). Ann Transl Med. 9:14332021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li X, Liao J, Su X, Li W, Bi Z, Wang J, Su
Q, Huang H, Wei Y, Gao Y, et al: Human urine-derived stem cells
protect against renal ischemia/reperfusion injury in a rat model
via exosomal miR-146a-5p which targets IRAK1. Theranostics.
10:9561–9578. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang XP, Luoreng ZM, Zan LS, Li F and Li
N: Bovine miR-146a regulates inflammatory cytokines of bovine
mammary epithelial cells via targeting the TRAF6 gene. J Dairy Sci.
100:7648–7658. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang X, Guo Y, Xu X, Tang T, Sun L, Wang
H, Zhou W, Fang L, Li Q and Xie P: miR-146a promotes Borna disease
virus 1 replication through IRAK1/TRAF6/NF-κB signaling pathway.
Virus Res. 271:1976712019. View Article : Google Scholar
|
|
40
|
Iori V, Iyer AM, Ravizza T, Beltrame L,
Paracchini L, Marchini S, Cerovic M, Hill C, Ferrari M, Zucchetti
M, et al: Blockade of the IL-1R1/TLR4 pathway mediates
disease-modification therapeutic effects in a model of acquired
epilepsy. Neurobiol Dis. 99:12–23. 2017. View Article : Google Scholar
|
|
41
|
Quinn EM, Wang JH, O'Callaghan G and
Redmond HP: MicroRNA-146a is upregulated by and negatively
regulates TLR2 signaling. PLoS One. 8:e622322013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen Y, Wu Z, Yuan B, Dong Y, Zhang L and
Zeng Z: MicroRNA-146a-5p attenuates irradiation-induced and
LPS-induced hepatic stellate cell activation and hepatocyte
apoptosis through inhibition of TLR4 pathway. Cell Death Dis.
9:222018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang L, Boldin MP, Yu Y, Liu CS, Ea CK,
Ramakrishnan P, Taganov KD, Zhao JL and Baltimore D: miR-146a
controls the resolution of T cell responses in mice. J Exp Med.
209:1655–1670. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lochhead RB, Ma Y, Zachary JF, Baltimore
D, Zhao JL, Weis JH, O'Connell RM and Weis JJ: MicroRNA-146a
provides feedback regulation of lyme arthritis but not carditis
during infection with Borrelia burgdorferi. PLoS Pathog.
10:e10042122014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bhatt K, Lanting LL, Jia Y, Yadav S, Reddy
MA, Magilnick N, Boldin M and Natarajan R: Anti-inflammatory role
of MicroRNA-146a in the pathogenesis of diabetic nephropathy. J Am
Soc Nephrol. 27:2277–2288. 2016. View Article : Google Scholar :
|
|
46
|
Ammari M, Presumey J, Ponsolles C,
Roussignol G, Roubert C, Escriou V, Toupet K, Mausset-Bonnefont AL,
Cren M, Robin M, et al: Delivery of miR-146a to Ly6Chigh
monocytes inhibits pathogenic bone erosion in inflammatory
arthritis. Theranostics. 8:5972–5985. 2018. View Article : Google Scholar
|
|
47
|
Hsu YR, Chang SW, Lin YC and Yang CH:
MicroRNA-146a alleviates experimental autoimmune anterior uveitis
in the eyes of lewis rats. Mediators Inflamm. 2017:96013492017.
View Article : Google Scholar
|
|
48
|
Lv F, Huang Y, Lv W, Yang L, Li F, Fan J
and Sun J: MicroRNA-146a ameliorates inflammation via TRAF6/NF-κB
pathway in intervertebral disc cells. Med Sci Monit. 23:659–664.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bi X, Zhou L, Liu Y, Gu J and Mi QS:
MicroRNA-146a deficiency delays wound healing in normal and
diabetic mice. Adv Wound Care (New Rochelle). 11:19–27. 2022.
View Article : Google Scholar
|
|
50
|
Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y,
Huang X, Zhou H, de Vries N, Tak PP, et al: MicroRNA-146A
contributes to abnormal activation of the type I interferon pathway
in human lupus by targeting the key signaling proteins. Arthritis
Rheum. 60:1065–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
He X, Tang R, Sun Y, Wang YG, Zhen KY,
Zhang DM and Pan WQ: MicroR-146 blocks the activation of M1
macrophage by targeting signal transducer and activator of
transcription 1 in hepatic schistosomiasis. EBioMedicine.
13:339–347. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen Y, Wang JJ, Li J, Hosoya KI, Ratan R,
Townes T and Zhang SX: Activating transcription factor 4 mediates
hyperglycaemia-induced endothelial inflammation and retinal
vascular leakage through activation of STAT3 in a mouse model of
type 1 diabetes. Diabetologia. 55:2533–2545. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Shirai T, Nazarewicz RR, Wallis BB, Yanes
RE, Watanabe R, Hilhorst M, Tian L, Harrison DG, Giacomini JC,
Assimes TL, et al: The glycolytic enzyme PKM2 bridges metabolic and
inflammatory dysfunction in coronary artery disease. J Exp Med.
213:337–354. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Elsaeidi F, Bemben MA, Zhao XF and Goldman
D: Jak/Stat signaling stimulates zebrafish optic nerve regeneration
and overcomes the inhibitory actions of Socs3 and Sfpq. J Neurosci.
34:2632–2644. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fasler-Kan E, Barteneva NS, Ketterer S,
Wunderlich K, Reschner A, Nurzhanova A, Flammer J, Huwyler J and
Meyer P: Human cytokines activate JAK-STAT signaling pathway in
porcine ocular tissue. Xenotransplantation. 20:469–480. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Samardzija M, Wenzel A, Aufenberg S,
Thiersch M, Remé C and Grimm C: Differential role of Jak-STAT
signaling in retinal degenerations. FASEB J. 20:2411–2413. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ye EA and Steinle JJ: miR-146a suppresses
STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in
primary human retinal microvascular endothelial cells in high
glucose conditions. Vision Res. 139:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Guo H, Zhang Y, Liao Z, Zhan W, Wang Y,
Peng Y, Yang M, Ma X, Yin G and Ye L: MiR-146a upregulates FOXP3
and suppresses inflammation by targeting HIPK3/STAT3 in allergic
conjunctivitis. Ann Transl Med. 10:3442022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li T, Li M, Xu C, Xu X, Ding J, Cheng L
and Ou R: miR-146a regulates the function of Th17 cell
differentiation to modulate cervical cancer cell growth and
apoptosis through NF-κB signaling by targeting TRAF6. Oncol Rep.
41:2897–2908. 2019.PubMed/NCBI
|
|
60
|
Ferrer-Marín F, Arroyo AB, Bellosillo B,
Cuenca EJ, Zamora L, Hernández-Rivas JM, Hernández-Boluda JC,
Fernandez-Rodriguez C, Luño E, García Hernandez C, et al: miR-146a
rs2431697 identifies myeloproliferative neoplasm patients with
higher secondary myelofibrosis progression risk. Leukemia.
34:2648–2659. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sun W, Ma J, Zhao H, Xiao C, Zhong H, Ling
H, Xie Z, Tian Q, Chen H, Zhang T, et al: Resolvin D1 suppresses
pannus formation via decreasing connective tissue growth factor
caused by upregulation of miRNA-146a-5p in rheumatoid arthritis.
Arthritis Res Ther. 22:612020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Dai X, Mao C, Lan X, Chen H, Li M, Bai J,
Deng J, Liang Q, Zhang J, Zhong X, et al: Acute Penicillium
marneffei infection stimulates host M1/M2a macrophages polarization
in BALB/C mice. BMC Microbiol. 17:1772017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Khan J, Sharma PK and Mukhopadhaya A:
Vibrio cholerae porin OmpU mediates M1-polarization of
macrophages/monocytes via TLR1/TLR2 activation. Immunobiology.
220:1199–1209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Vinuesa E, Hotter G, Jung M,
Herrero-Fresneda I, Torras J and Sola A: Macrophage involvement in
the kidney repair phase after ischaemia/reperfusion injury. J
Pathol. 214:104–113. 2008. View Article : Google Scholar
|
|
65
|
Huen SC and Cantley LG:
Macrophage-mediated injury and repair after ischemic kidney injury.
Pediatr Nephrol. 30:199–209. 2015. View Article : Google Scholar
|
|
66
|
Lee S, Huen S, Nishio H, Nishio S, Lee HK,
Choi BS, Ruhrberg C and Cantley LG: Distinct macrophage phenotypes
contribute to kidney injury and repair. J Am Soc Nephrol.
22:317–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Alikhan MA, Jones CV, Williams TM,
Beckhouse AG, Fletcher AL, Kett MM, Sakkal S, Samuel CS, Ramsay RG,
Deane JA, et al: Colony-stimulating factor-1 promotes kidney growth
and repair via alteration of macrophage responses. Am J Pathol.
179:1243–1256. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Peng X, He F, Mao Y, Lin Y, Fang J, Chen
Y, Sun Z, Zhuo Y and Jiang J: miR-146a promotes M2 macrophage
polarization and accelerates diabetic wound healing by inhibiting
the TLR4/NF-κB axis. J Mol Endocrinol. 69:315–327. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Liu XS, Fan B, Szalad A, Jia L, Wang L,
Wang X, Pan W, Zhang L, Zhang R, Hu J, et al: MicroRNA-146a mimics
reduce the peripheral neuropathy in type 2 diabetic mice. Diabetes.
66:3111–3121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Huang C, Liu XJ, QunZhou, Xie J, Ma TT,
Meng XM and Li J: MiR-146a modulates macrophage polarization by
inhibiting Notch1 pathway in RAW264.7 macrophages. Int
Immunopharmacol. 32:46–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Jiang M, Xiang Y, Wang D, Gao J, Liu D,
Liu Y, Liu S and Zheng D: Dysregulated expression of miR-146a
contributes to age-related dysfunction of macrophages. Aging Cell.
11:29–40. 2012. View Article : Google Scholar
|
|
72
|
Li Z, Wang S, Zhao W, Sun Z, Yan H and Zhu
J: Oxidized low-density lipoprotein upregulates microRNA-146a via
JNK and NF-κB signaling. Mol Med Rep. 13:1709–1716. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yang Y, Huang G, Xu Q, Zhao G, Jiang J, Li
Y and Guo Z: miR-146a-5p attenuates allergic airway inflammation by
inhibiting the NLRP3 inflammasome activation in macrophages. Int
Arch Allergy Immunol. 183:919–930. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chen X, Su C, Wei Q, Sun H, Xie J and Nong
G: Exosomes derived from human umbilical cord mesenchymal stem
cells alleviate diffuse alveolar hemorrhage associated with
systemic lupus erythematosus in mice by promoting M2 macrophage
polarization via the microRNA-146a-5p/NOTCH1 axis. Immunol Invest.
51:1975–1993. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Luo S, Ding X, Zhao S, Mou T, Li R and Cao
X: Long non-coding RNA CHRF accelerates LPS-induced acute lung
injury through microRNA-146a/Notch1 axis. Ann Transl Med.
9:12992021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ren W, Xi G, Li X, Zhao L, Yang K, Fan X,
Gao L, Xu H and Guo J: Long non-coding RNA HCG18 promotes M1
macrophage polarization through regulating the miR-146a/TRAF6 axis,
facilitating the progression of diabetic peripheral neuropathy. Mol
Cell Biochem. 476:471–482. 2021. View Article : Google Scholar
|
|
77
|
Cobb BS, Hertweck A, Smith J, O'Connor E,
Graf D, Cook T, Smale ST, Sakaguchi S, Livesey FJ, Fisher AG and
Merkenschlager M: A role for Dicer in immune regulation. J Exp Med.
203:2519–2527. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Smigielska-Czepiel K, van den Berg A,
Jellema P, van der Lei RJ, Bijzet J, Kluiver J, Boots AM, Brouwer E
and Kroesen BJ: Comprehensive analysis of miRNA expression in
T-cell subsets of rheumatoid arthritis patients reveals defined
signatures of naive and memory Tregs. Genes Immun. 15:115–125.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang Y, Yang Y, Guo J, Cui L, Yang L, Li
Y, Mou Y, Jia C, Zhang L and Song X: miR-146a enhances regulatory
T-cell differentiation and function in allergic rhinitis by
targeting STAT5b. Allergy. 77:550–558. 2022. View Article : Google Scholar
|
|
80
|
Li B, Wang X, Choi IY, Wang YC, Liu S,
Pham AT, Moon H, Smith DJ, Rao DS, Boldin MP and Yang L: miR-146a
modulates autoreactive Th17 cell differentiation and regulates
organ-specific autoimmunity. J Clin Invest. 127:3702–3716. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wang J, Yang L, Wang L, Yang Y and Wang Y:
Forkhead box p3 controls progression of oral lichen planus by
regulating microRNA-146a. J Cell Biochem. 119:8862–8871. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang J, Zhai X, Guo J, Li Y, Yang Y, Wang
L, Yang L and Liu F: Long non-coding RNA DQ786243 modulates the
induction and function of CD4+ Treg cells through
Foxp3-miR-146a-NF-κB axis: Implications for alleviating oral lichen
planus. Int Immunopharmacol. 75:1057612019. View Article : Google Scholar
|
|
83
|
Schmidt SV, Nino-Castro AC and Schultze
JL: Regulatory dendritic cells: There is more than just immune
activation. Front Immunol. 3:2742012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Tang H, Lai Y, Zheng J, Chen K, Jiang H
and Xu G: MiR-146a promotes tolerogenic properties of dendritic
cells and through targeting notch1 signaling. Immunol Invest.
49:555–570. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Du J, Wang J, Tan G, Cai Z, Zhang L, Tang
B and Wang Z: Aberrant elevated microRNA-146a in dendritic cells
(DC) induced by human pancreatic cancer cell line
BxPC-3-conditioned medium inhibits DC maturation and activation.
Med Oncol. 29:2814–2823. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Stickel N, Hanke K, Marschner D, Prinz G,
Köhler M, Melchinger W, Pfeifer D, Schmitt-Graeff A, Brummer T,
Heine A, et al: MicroRNA-146a reduces MHC-II expression via
targeting JAK/STAT signaling in dendritic cells after stem cell
transplantation. Leukemia. 31:2732–2741. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Jurkin J, Schichl YM, Koeffel R, Bauer T,
Richter S, Konradi S, Gesslbauer B and Strobl H: miR-146a is
differentially expressed by myeloid dendritic cell subsets and
desensitizes cells to TLR2-dependent activation. J Immunol.
184:4955–4965. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Karrich JJ, Jachimowski LC, Libouban M,
Iyer A, Brandwijk K, Taanman-Kueter EW, Nagasawa M, de Jong EC,
Uittenbogaart CH and Blom B: MicroRNA-146a regulates survival and
maturation of human plasmacytoid dendritic cells. Blood.
122:3001–3009. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Park H, Huang X, Lu C, Cairo MS and Zhou
X: MicroRNA-146a and microRNA-146b regulate human dendritic cell
apoptosis and cytokine production by targeting TRAF6 and IRAK1
proteins. J Biol Chem. 290:2831–2841. 2015. View Article : Google Scholar :
|
|
90
|
Xu D, Han Q, Hou Z, Zhang C and Zhang J:
miR-146a negatively regulates NK cell functions via STAT1
signaling. Cell Mol Immunol. 14:712–720. 2017. View Article : Google Scholar :
|
|
91
|
Pesce S, Squillario M, Greppi M, Loiacono
F, Moretta L, Moretta A, Sivori S, Castagnola P, Barla A, Candiani
S and Marcenaro E: New miRNA signature heralds human NK cell
subsets at different maturation steps: Involvement of miR-146a-5p
in the regulation of KIR expression. Front Immunol. 9:23602018.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wang H, Zhang Y, Wu X, Wang Y, Cui H, Li
X, Zhang J, Tun N, Peng Y and Yu J: Regulation of human natural
killer cell IFN-γ production by MicroRNA-146a via targeting the
NF-κB signaling pathway. Front Immunol. 9:2932018. View Article : Google Scholar
|
|
93
|
Friedman SL, Sheppard D, Duffield JS and
Violette S: Therapy for fibrotic diseases: Nearing the starting
line. Sci Transl Med. 5:167sr12013. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Rosenbloom J, Mendoza FA and Jimenez SA:
Strategies for anti-fibrotic therapies. Biochim Biophys Acta.
1832:1088–1103. 2013. View Article : Google Scholar
|
|
95
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
McAnulty RJ: Fibroblasts and
myofibroblasts: Their source, function and role in disease. Int J
Biochem Cell Biol. 39:666–671. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Beyer C, Schett G, Gay S, Distler O and
Distler JHW: Hypoxia. Hypoxia in the pathogenesis of systemic
sclerosis. Arthritis Res Ther. 11:2202009. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Lokmic Z, Musyoka J, Hewitson TD and Darby
IA: Hypoxia and hypoxia signaling in tissue repair and fibrosis.
Int Rev Cell Mol Biol. 296:139–185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Santos A and Lagares D: Matrix stiffness:
The conductor of organ fibrosis. Curr Rheumatol Rep. 20:22018.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Parker MW, Rossi D, Peterson M, Smith K,
Sikström K, White ES, Connett JE, Henke CA, Larsson O and Bitterman
PB: Fibrotic extracellular matrix activates a profibrotic positive
feedback loop. J Clin Invest. 124:1622–1635. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Watson CJ, Collier P, Tea I, Neary R,
Watson JA, Robinson C, Phelan D, Ledwidge MT, McDonald KM, McCann
A, et al: Hypoxia-induced epigenetic modifications are associated
with cardiac tissue fibrosis and the development of a
myofibroblast-like phenotype. Hum Mol Genet. 23:2176–2188. 2014.
View Article : Google Scholar
|
|
102
|
Kanzler S, Lohse AW, Keil A, Henninger J,
Dienes HP, Schirmacher P, Rose-John S, zum Büschenfelde KH and
Blessing M: TGF-beta1 in liver fibrosis: An inducible transgenic
mouse model to study liver fibrogenesis. Am J Physiol.
276:G1059–G1068. 1999.
|
|
103
|
Zhu H, Li Y, Qu S, Luo H, Zhou Y, Wang Y,
Zhao H, You Y, Xiao X and Zuo X: MicroRNA expression abnormalities
in limited cutaneous scleroderma and diffuse cutaneous scleroderma.
J Clin Immunol. 32:514–522. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Jia C, Xiong M, Wang P, Cui J, Du X, Yang
Q, Wang W, Chen Y and Zhang T: Notoginsenoside R1 attenuates
atherosclerotic lesions in ApoE deficient mouse model. PLoS One.
9:e998492014. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Morishita Y, Imai T, Yoshizawa H, Watanabe
M, Ishibashi K, Muto S and Nagata D: Delivery of microRNA-146a with
polyethylenimine nanoparticles inhibits renal fibrosis in vivo. Int
J Nanomedicine. 10:3475–3488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Liu Z, Lu CL, Cui LP, Hu YL, Yu Q, Jiang
Y, Ma T, Jiao DK, Wang D and Jia CY: MicroRNA-146a modulates
TGF-β1-induced phenotypic differentiation in human dermal
fibroblasts by targeting SMAD4. Arch Dermatol Res. 304:195–202.
2012. View Article : Google Scholar
|
|
107
|
Zou Y, Cai Y, Lu D, Zhou Y, Yao Q and
Zhang S: MicroRNA-146a-5p attenuates liver fibrosis by suppressing
profibrogenic effects of TGFβ1 and lipopolysaccharide. Cell Signal.
39:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Skhirtladze C, Distler O, Dees C,
Akhmetshina A, Busch N, Venalis P, Zwerina J, Spriewald B,
Pileckyte M, Schett G and Distler JH: Src kinases in systemic
sclerosis: Central roles in fibroblast activation and in skin
fibrosis. Arthritis Rheum. 58:1475–1484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Hu M, Che P, Han X, Cai GQ, Liu G, Antony
V, Luckhardt T, Siegal GP, Zhou Y, Liu RM, et al: Therapeutic
targeting of SRC kinase in myofibroblast differentiation and
pulmonary fibrosis. J Pharmacol Exp Ther. 351:87–95. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Yuan BY, Chen YH, Wu ZF, Zhuang Y, Chen
GW, Zhang L, Zhang HG, Cheng JC, Lin Q and Zeng ZC:
MicroRNA-146a-5p attenuates fibrosis-related molecules in
irradiated and TGF-beta1-treated human hepatic stellate cells by
regulating PTPRA-SRC signaling. Radiat Res. 192:621–629. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Sun Y, Li Y, Wang H, Li H, Liu S, Chen J
and Ying H: miR-146a-5p acts as a negative regulator of TGF-β
signaling in skeletal muscle after acute contusion. Acta Biochim
Biophys Sin (Shanghai). 49:628–634. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Liu W, Ma C, Li HY, Chen L, Yuan SS and Li
KJ: MicroRNA-146a downregulates the production of hyaluronic acid
and collagen I in Graves' ophthalmopathy orbital fibroblasts. Exp
Ther Med. 20:382020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Amrouche L, Desbuissons G, Rabant M,
Sauvaget V, Nguyen C, Benon A, Barre P, Rabaté C, Lebreton X,
Gallazzini M, et al: MicroRNA-146a in human and experimental
ischemic AKI: CXCL8-dependent mechanism of action. J Am Soc
Nephrol. 28:479–493. 2017. View Article : Google Scholar :
|
|
114
|
Xiao Y, Qiao W, Wang X, Sun L and Ren W:
MiR-146a mediates TLR-4 signaling pathway to affect myocardial
fibrosis in rat constrictive pericarditis model. J Thorac Dis.
13:935–945. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Yoshimura A, Wakabayashi Y and Mori T:
Cellular and molecular basis for the regulation of inflammation by
TGF-beta. J Biochem. 147:781–792. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Sisto M, Lorusso L, Ingravallo G, Tamma R,
Ribatti D and Lisi S: The TGF-β1 signaling pathway as an attractive
target in the fibrosis pathogenesis of Sjögren's syndrome.
Mediators Inflamm. 2018:19659352018. View Article : Google Scholar
|
|
117
|
Biernacka A, Dobaczewski M and
Frangogiannis NG: TGF-β signaling in fibrosis. Growth Factors.
29:196–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Meng XM, Nikolic-Paterson DJ and Lan HY:
TGF-β: The master regulator of fibrosis. Nat Rev Nephrol.
12:325–338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
He Y, Huang C, Sun X, Long XR, Lv XW and
Li J: MicroRNA-146a modulates TGF-beta1-induced hepatic stellate
cell proliferation by targeting SMAD4. Cell Signal. 24:1923–1930.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Wrighton KH, Lin X and Feng XH:
Phospho-control of TGF-beta superfamily signaling. Cell Res.
19:8–20. 2009. View Article : Google Scholar
|
|
121
|
Hill CS: Transcriptional control by the
SMADs. Cold Spring Harb Perspect Biol. 8:a0220792016. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Kaufhold S and Bonavida B: Central role of
Snail1 in the regulation of EMT and resistance in cancer: A target
for therapeutic intervention. J Exp Clin Cancer Res. 33:622014.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhang Q, Cai R, Tang G, Zhang W and Pang
W: MiR-146a-5p targeting SMAD4 and TRAF6 inhibits adipogenensis
through TGF-β and AKT/mTORC1 signal pathways in porcine
intra-muscular preadipocytes. J Anim Sci Biotechnol. 12:122021.
View Article : Google Scholar
|
|
124
|
Milano G, Biemmi V, Lazzarini E, Balbi C,
Ciullo A, Bolis S, Ameri P, Di Silvestre D, Mauri P, Barile L and
Vassalli G: Intravenous administration of cardiac progenitor
cell-derived exosomes protects against
doxorubicin/trastuzumab-induced cardiac toxicity. Cardiovasc Res.
116:383–392. 2020.
|
|
125
|
Sisto M, Ribatti D and Lisi S: Organ
fibrosis and autoimmunity: The role of inflammation in
TGFβ-dependent EMT. Biomolecules. 11:3102021. View Article : Google Scholar
|
|
126
|
Onichtchouk D, Chen YG, Dosch R, Gawantka
V, Delius H, Massagué J and Niehrs C: Silencing of TGF-beta
signalling by the pseudoreceptor BAMBI. Nature. 401:480–485. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning
Y and Chen YG: Human BAMBI cooperates with Smad7 to inhibit
transforming growth factor-beta signaling. J Biol Chem.
284:30097–30104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Jiang Y, Xiang C, Zhong F, Zhang Y, Wang
L, Zhao Y, Wang J, Ding C, Jin L, He F and Wang H: Histone H3K27
methyltransferase EZH2 and demethylase JMJD3 regulate hepatic
stellate cells activation and liver fibrosis. Theranostics.
11:361–378. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Liu C, Chen X, Yang L, Kisseleva T,
Brenner DA and Seki E: Transcriptional repression of the
transforming growth factor β (TGF-β) pseudoreceptor BMP and activin
membrane-bound inhibitor (BAMBI) by nuclear factor κB (NF-κB) p50
enhances TGF-β signaling in hepatic stellate cells. J Biol Chem.
289:7082–7091. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Seki E, De Minicis S, Osterreicher CH,
Kluwe J, Osawa Y, Brenner DA and Schwabe RF: TLR4 enhances TGF-beta
signaling and hepatic fibrosis. Nat Med. 13:1324–1332. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Wiest R, Lawson M and Geuking M:
Pathological bacterial translocation in liver cirrhosis. J Hepatol.
60:197–209. 2014. View Article : Google Scholar
|
|
132
|
Pradere JP, Troeger JS, Dapito DH, Mencin
AA and Schwabe RF: Toll-like receptor 4 and hepatic fibrogenesis.
Semin Liver Dis. 30:232–244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Akira S and Takeda K: Toll-like receptor
signalling. Nat Rev Immunol. 4:499–511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Maubach G, Lim MCC, Chen J, Yang H and
Zhuo L: miRNA studies in in vitro and in vivo activated hepatic
stellate cells. World J Gastroenterol. 17:2748–2773. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Chen Y, Zeng Z, Shen X, Wu Z, Dong Y and
Cheng JC: MicroRNA-146a-5p negatively regulates pro-inflammatory
cytokine secretion and cell activation in lipopolysaccharide
stimulated human hepatic stellate cells through inhibition of
Toll-like receptor 4 signaling pathways. Int J Mol Sci.
17:10762016. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Xiao L, Gu Y, Ren G, Chen L, Liu L, Wang X
and Gao L: miRNA-146a mimic inhibits NOX4/P38 signalling to
ameliorate mouse myocardial ischaemia reperfusion (I/R) injury.
Oxid Med Cell Longev. 2021:63662542021. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Li J, Jiang ZZ, Li YY, Tang WT, Yin J and
Long XP: LncRNA CHRF promotes TGF-β1 induced EMT in alveolar
epithelial cells by inhibiting miR-146a up-regulating L1CAM
expression. Exp Lung Res. 47:198–209. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Feng B, Chen S, Gordon AD and Chakrabarti
S: miR-146a mediates inflammatory changes and fibrosis in the heart
in diabetes. J Mol Cell Cardiol. 105:70–76. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Chen Y, Yuan B, Chen G, Zhang L, Zhuang Y,
Niu H and Zeng Z: Circular RNA RSF1 promotes inflammatory and
fibrotic phenotypes of irradiated hepatic stellate cell by
modulating miR-146a-5p. J Cell Physiol. 235:8270–8282. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Du J, Niu X, Wang Y, Kong L, Wang R, Zhang
Y, Zhao S and Nan Y: MiR-146a-5p suppresses activation and
proliferation of hepatic stellate cells in nonalcoholic fibrosing
steatohepatitis through directly targeting Wnt1 and Wnt5a. Sci Rep.
5:161632015. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Zhang H, Wen H and Huang Y: MicroRNA-146a
attenuates isoproterenol-induced cardiac fibrosis by inhibiting
FGF2. Exp Ther Med. 24:5062022. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Editorial Office: Erratum to MiR-146a
mediates TLR-4 signaling pathway to affect myocardial fibrosis in
rat constrictive pericarditis model. J Thorac Dis. 13:4623–4624.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Ma C, Qi X, Wei YF, Li Z, Zhang HL, Li H,
Yu FL, Pu YN, Huang YC and Ren YX: Amelioration of ligamentum
flavum hypertrophy using umbilical cord mesenchymal stromal
cell-derived extracellular vesicles. Bioact Mater. 19:139–154.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Saferding V, Puchner A, Goncalves-Alves E,
Hofmann M, Bonelli M, Brunner JS, Sahin E, Niederreiter B, Hayer S,
Kiener HP, et al: MicroRNA-146a governs fibroblast activation and
joint pathology in arthritis. J Autoimmun. 82:74–84. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Jang SY, Park SJ, Chae MK, Lee JH, Lee EJ
and Yoon JS: Role of microRNA-146a in regulation of fibrosis in
orbital fibroblasts from patients with Graves' orbitopathy. Br J
Ophthalmol. 102:407–414. 2018. View Article : Google Scholar
|
|
146
|
Acharya PS, Majumdar S, Jacob M, Hayden J,
Mrass P, Weninger W, Assoian RK and Puré E: Fibroblast migration is
mediated by CD44-dependent TGF beta activation. J Cell Sci.
121:1393–1402. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Clark RA, McCoy GA, Folkvord JM and
McPherson JM: TGF-beta 1 stimulates cultured human fibroblasts to
proliferate and produce tissue-like fibroplasia: A fibronectin
matrix-dependent event. J Cell Physiol. 170:69–80. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Saha B, Kodys K and Szabo G: Hepatitis C
virus-induced monocyte differentiation into polarized M2
macrophages promotes stellate cell activation via TGF-β. Cell Mol
Gastroenterol Hepatol. 2:302–316.e8. 2016. View Article : Google Scholar
|
|
149
|
Tang PM, Zhou S, Li CJ, Liao J, Xiao J,
Wang QM, Lian GY, Li J, Huang XR, To KF, et al: The proto-oncogene
tyrosine protein kinase Src is essential for
macrophage-myofibroblast transition during renal scarring. Kidney
Int. 93:173–187. 2018. View Article : Google Scholar
|
|
150
|
Long H, Wang X, Chen Y, Wang L, Zhao M and
Lu Q: Dysregulation of microRNAs in autoimmune diseases:
Pathogenesis, biomarkers and potential therapeutic targets. Cancer
Lett. 428:90–103. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Shumnalieva R, Kachakova D,
Shoumnalieva-Ivanova V, Miteva P, Kaneva R and Monov S: Whole
peripheral blood miR-146a and miR-155 expression levels in systemic
lupus erythematosus patients. Acta Reumatol Port. 43:217–225.
2018.PubMed/NCBI
|
|
152
|
Zhu Y, Xue Z and Di L: Regulation of
MiR-146a and TRAF6 in the diagnose of lupus nephritis. Med Sci
Monit. 23:2550–2557. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Abou-Zeid A, Saad M and Soliman E:
MicroRNA 146a expression in rheumatoid arthritis: Association with
tumor necrosis factor-alpha and disease activity. Genet Test Mol
Biomarkers. 15:807–812. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Li N, Wang J, Yu W, Dong K, You F, Si B,
Tang B, Zhang Y, Wang T and Qiao B: MicroRNA-146a inhibits the
inflammatory responses induced by interleukin-17A during the
infection of Helicobacter pylori. Mol Med Rep. 19:1388–1395.
2019.
|
|
155
|
Li LJ, Gu YJ, Wang LQ, Wan W, Wang HW,
Yang XN, Ma LL, Yang LH and Meng ZH: Serum exosomal microRNA-146a
as a novel diagnostic biomarker for acute coronary syndrome. J
Thorac Dis. 13:3105–3114. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu
J, Sun Z and Shen WF: MiR-146a inhibits oxidized low-density
lipoprotein-induced lipid accumulation and inflammatory response
via targeting toll-like receptor 4. FEBS Lett. 585:854–860. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Wu W, Xuan Y, Ge Y, Mu S, Hu C and Fan R:
Plasma miR-146a and miR-365 expression and inflammatory factors in
patients with osteoarthritis. Malays J Pathol. 43:311–317.
2021.PubMed/NCBI
|
|
158
|
Ghotloo S, Motedayyen H, Amani D, Saffari
M and Sattari M: Assessment of microRNA-146a in generalized
aggressive periodontitis and its association with disease severity.
J Periodontal Res. 54:27–32. 2019. View Article : Google Scholar
|
|
159
|
Sabbatinelli J, Giuliani A, Matacchione G,
Latini S, Laprovitera N, Pomponio G, Ferrarini A, Svegliati Baroni
S, Pavani M, Moretti M, et al: Decreased serum levels of the
inflammaging marker miR-146a are associated with clinical
non-response to tocilizumab in COVID-19 patients. Mech Ageing Dev.
193:1114132021. View Article : Google Scholar
|
|
160
|
Cai P, Mu Y, Olveda RM, Ross AG, Olveda DU
and McManus DP: Serum exosomal miRNAs for grading hepatic fibrosis
due to schistosomiasis. Int J Mol Sci. 21:35602020. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Cai P, Mu Y, Olveda RM, Ross AG, Olveda DU
and McManus DP: Circulating miRNAs as footprints for liver fibrosis
grading in schistosomiasis. EBioMedicine. 37:334–343. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Chen J, Chen T, Zhou J, Zhao X, Sheng Q
and Lv Z: MiR-146a-5p mimic inhibits NLRP3 inflammasome downstream
inflammatory factors and CLIC4 in neonatal necrotizing
enterocolitis. Front Cell Dev Biol. 8:5941432021. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Wang Y, Zhang S and Benoit DSW: Degradable
poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal
control of siRNA/nanoparticle delivery. J Control Release.
287:58–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Niemiec SM, Hilton SA, Wallbank A,
Azeltine M, Louiselle AE, Elajaili H, Allawzi A, Xu J, Mattson C,
Dewberry LC, et al: Cerium oxide nanoparticle delivery of
microRNA-146a for local treatment of acute lung injury.
Nanomedicine. 34:1023882021. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Chen B, Yoo K, Xu W, Pan R, Han XX and
Chen P: Characterization and evaluation of a peptide-based siRNA
delivery system in vitro. Drug Deliv Transl Res. 7:507–515. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Su Y, Sun B, Gao X, Liu S, Hao R and Han
B: Chitosan hydrogel doped with PEG-PLA nanoparticles for the local
delivery of miRNA-146a to treat allergic rhinitis. Pharmaceutics.
12:9072020. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Chiabotto G, Ceccotti E, Tapparo M,
Camussi G and Bruno S: Human liver stem cell-derived extracellular
vesicles target hepatic stellate cells and attenuate their
pro-fibrotic phenotype. Front Cell Dev Biol. 9:7774622021.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Liang YC, Wu YP, Li XD, Chen SH, Ye XJ,
Xue XY and Xu N: TNF-α-induced exosomal miR-146a mediates
mesenchymal stem cell-dependent suppression of urethral stricture.
J Cell Physiol. 234:23243–23255. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Shafei S, Khanmohammadi M, Ghanbari H,
Nooshabadi VT, Tafti SHA, Rabbani S, Kasaiyan M, Basiri M and
Tavoosidana G: Effectiveness of exosome mediated miR-126 and
miR-146a delivery on cardiac tissue regeneration. Cell Tissue Res.
390:71–92. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Carreras-Badosa G, Maslovskaja J,
Periyasamy K, Urgard E, Padari K, Vaher H, Tserel L, Gestin M,
Kisand K, Arukuusk P, et al: NickFect type of cell-penetrating
peptides present enhanced efficiency for microRNA-146a delivery
into dendritic cells and during skin inflammation. Biomaterials.
262:1203162020. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Wang WX, Prajapati P, Vekaria HJ, Spry M,
Cloud AL, Sullivan PG and Springer JE: Temporal changes in
inflammatory mitochondria-enriched microRNAs following traumatic
brain injury and effects of miR-146a nanoparticle delivery. Neural
Regen Res. 16:514–522. 2021. View Article : Google Scholar :
|
|
172
|
Bobba CM, Fei Q, Shukla V, Lee H, Patel P,
Putman RK, Spitzer C, Tsai M, Wewers MD, Lee RJ, et al:
Nanoparticle delivery of microRNA-146a regulates
mechanotransduction in lung macrophages and mitigates injury during
mechanical ventilation. Nat Commun. 12:2892021. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Fouad MR, Salama RM, Zaki HF and El-Sahar
AE: Vildagliptin attenuates acetic acid-induced colitis in rats via
targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the
expression of lncRNA IFNG-AS1 and miR-146a. Int Immunopharmacol.
92:1073542021. View Article : Google Scholar
|
|
174
|
Pan Y, Wang J, Xue Y, Zhao J, Li D, Zhang
S, Li K, Hou Y and Fan H: GSKJ4 protects mice against early sepsis
via reducing proinflammatory factors and up-regulating MiR-146a.
Front Immunol. 9:22722018. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Sun W, Ma M and Yu H and Yu H: Inhibition
of lncRNA X inactivate-specific transcript ameliorates inflammatory
pain by suppressing satellite glial cell activation and
inflammation by acting as a sponge of miR-146a to inhibit
Nav 1.7. J Cell Biochem. 119:9888–9898. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Zhou Z, Zhu Y, Gao G and Zhang Y: Long
noncoding RNA SNHG16 targets miR-146a-5p/CCL5 to regulate
LPS-induced WI-38 cell apoptosis and inflammation in acute
pneumonia. Life Sci. 228:189–197. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Dai L, Zhang G, Cheng Z, Wang X, Jia L,
Jing X, Wang H, Zhang R, Liu M, Jiang T, et al: Knockdown of LncRNA
MALAT1 contributes to the suppression of inflammatory responses by
up-regulating miR-146a in LPS-induced acute lung injury. Connect
Tissue Res. 59:581–592. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Zhu D, Hu B, Zhou Y, Sun X, Chen J, Chen
L, Ji Z, Zhu J and Duan Y: microRNA-146a is involved in
rSjP40-inhibited activation of LX-2 cells by targeting Smad4
expression. J Cell Biochem. 119:9249–9253. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Madhavan D, Cuk K, Burwinkel B and Yang R:
Cancer diagnosis and prognosis decoded by blood-based circulating
microRNA signatures. Front Genet. 4:1162013. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Li Y, Zhang S, Zhang C and Wang M: LncRNA
MEG3 inhibits the inflammatory response of ankylosing spondylitis
by targeting miR-146a. Mol Cell Biochem. 466:17–24. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Stenvang J, Petri A, Lindow M, Obad S and
Kauppinen S: Inhibition of microRNA function by antimiR
oligonucleotides. Silence. 3:12012. View Article : Google Scholar : PubMed/NCBI
|
